2021
DOI: 10.2174/2210303110999201105154422
|View full text |Cite
|
Sign up to set email alerts
|

Bioadhesive Films as Drug Delivery Systems

Abstract: : Bioadhesive films are considered as a novel drug delivery system which provides improved therapy and better patient compliance than conventional dosage forms. The type and concentration of polymer or the blend of polymers used are important factors influencing the properties of bioadhesive films and influencingthe product outcome and performance. But the modification of available polymers to synthesize polymers with improved properties is the current area of research. Furthermore, addressing the challenges i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 98 publications
0
3
0
Order By: Relevance
“…This can result in poor retention and reduced efficacy of drug delivery systems and biomedical devices [ 143 ]. Poor bioadhesion is a common challenge associated with unmodified polymers used in drug delivery systems [ 144 ]. Unmodified PLGA nanoparticles have been found to have poor mucoadhesive properties, which can limit their effectiveness in mucosal drug delivery applications [ 145 ].…”
Section: Challenges and Future Directionsmentioning
confidence: 99%
“…This can result in poor retention and reduced efficacy of drug delivery systems and biomedical devices [ 143 ]. Poor bioadhesion is a common challenge associated with unmodified polymers used in drug delivery systems [ 144 ]. Unmodified PLGA nanoparticles have been found to have poor mucoadhesive properties, which can limit their effectiveness in mucosal drug delivery applications [ 145 ].…”
Section: Challenges and Future Directionsmentioning
confidence: 99%
“…Drug-drug interactions can occur when drug-metabolizing enzymes are inhibited or activated, leading to higher or lower drug levels (Hines, 2013). been reported as reasons for not being able to deliver medication as prescribed (Matsui, 2007;Malkawi et al, 2022;Singh et al, 2021).…”
Section: Pharmacokineticsmentioning
confidence: 99%
“…In order to treat local conditions of ano-rectal pruritus, inflammation, the pain and discomfort associated with hemorrhoids, semi-solid rectal dosage forms are used, which provide better retention time in the rectum as compared to other dosage forms, and reduce patient compliance issues and increase the drug release [ 7 ].…”
Section: Factors Influencing Rectal Drug Deliverymentioning
confidence: 99%